Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
105.35
+0.36 (0.34%)
At close: Nov 13, 2026, 4:00 PM EST
106.15
+0.80 (0.76%)
After-hours: Nov 13, 2026, 7:30 PM EST
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $130 | Buy | Maintains | $130 | +23.40% | Nov 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +70.86% | Nov 10, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $200 | Buy | Reiterates | $200 | +89.84% | Nov 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $150 | Buy | Reiterates | $150 | +42.38% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +13.91% | Nov 10, 2026 |
| BTIG | BTIG | Buy Reiterates $151 | Buy | Reiterates | $151 | +43.33% | Nov 10, 2026 |
| Barclays | Barclays | Buy Maintains $160 | Buy | Maintains | $160 | +51.87% | Nov 10, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.